2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Intestinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Courtois, P; Malaisse, WJ; Scott, FW; Sener, A | 1 |
| Courtois, P; Graham, S; Malaisse, WJ; Mowat, AM; Rozing, J; Scott, FW | 1 |
2 other study(ies) available for 2,2-bis(bromomethyl)-1,3-propanediol and Intestinal Diseases
| Article | Year |
|---|---|
Disaccharidase activity in the intestinal tract of Wistar-Furth, diabetes-resistant and diabetes-prone BioBreeding rats.
Topics: alpha-Glucosidases; Animals; beta-Fructofuranosidase; Diabetes Mellitus, Experimental; Diet; Disaccharidases; Female; Genetic Predisposition to Disease; Intestinal Diseases; Intestine, Small; Lactase; Male; Prediabetic State; Rats; Rats, Inbred BB; Sex Factors; Species Specificity | 2004 |
Enteropathy precedes type 1 diabetes in the BB rat.
Topics: Animals; beta-Fructofuranosidase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diet; Female; Intestinal Diseases; Intestinal Mucosa; Jejunum; Male; Prediabetic State; Rats; Rats, Inbred BB; Thymus Gland | 2004 |